Dymon Asia Capital (Singapore)’s Axsome Therapeutics AXSM Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$979K	Buy	+4,000	New	+$867K	0.04%	164

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s AXSM Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 4,000 shares worth $979K. The stake represents 0.04% of the portfolio and ranks #164 among its holdings.

113 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Dymon Asia Capital (Singapore) held 4,000 shares of Axsome Therapeutics worth $979K as of Q2 2026.
Axsome Therapeutics was a new Dymon Asia Capital (Singapore) position in Q2 2026.
Axsome Therapeutics made up 0.04% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #164 holding.
113 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.